However, it is recommended to follow up with patients with elevated ALT, AST, and GGT since they correlate with the fibrosis progression in NAFLD (Oh et al. 2017; Sanyal et al. 2015; Canbakan et al. 2007). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.